Human mast cells express functional TrkA and are a source of nerve growth factor.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 9341772)

Published in Eur J Immunol on September 01, 1997

Authors

G Nilsson1, K Forsberg-Nilsson, Z Xiang, F Hallböök, K Nilsson, D D Metcalfe

Author Affiliations

1: Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA. Gunnar.Nilsson@patologi.uu.se

Articles citing this

Mast cells and mastocytosis. Blood (2008) 2.32

Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia. Dig Dis Sci (2011) 2.02

Is liver fibrosis reversible? Gut (2000) 1.52

The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Neuroscience (2011) 1.16

Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J Pain (2011) 1.06

Overview on the pathomechanisms of allergic rhinitis. Asia Pac Allergy (2011) 1.05

How exposures to biologics influence the induction and incidence of asthma. Environ Health Perspect (2006) 1.05

Role of interleukins, IGF and stem cells in BPH. Differentiation (2011) 0.97

Immune cells and angiogenesis. J Cell Mol Med (2009) 0.96

What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine. Br J Sports Med (2004) 0.92

Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis. Ann Rheum Dis (2015) 0.87

NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling. Adv Biol Regul (2014) 0.85

Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology (1998) 0.83

NGF accelerates cutaneous wound healing by promoting the migration of dermal fibroblasts via the PI3K/Akt-Rac1-JNK and ERK pathways. Biomed Res Int (2014) 0.82

Repeated muscle injury as a presumptive trigger for chronic masticatory muscle pain. Pain Res Treat (2011) 0.81

High abundances of neurotrophin 3 in atopic dermatitis mast cell. J Occup Med Toxicol (2009) 0.80

Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology (2000) 0.80

Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis. Immunology (2006) 0.80

Effects of nerve growth factor on nerve regeneration after corneal nerve damage. Int J Clin Exp Med (2014) 0.77

Nerve growth factor: a neuroimmune crosstalk mediator for all seasons. Immunology (2017) 0.75

Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain. Mol Pain (2017) 0.75

Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer. Front Med (Lausanne) (2017) 0.75

Articles by these authors

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69

The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26

Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08

Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85

The genome of the sea urchin Strongylocentrotus purpuratus. Science (2006) 6.41

Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med (1994) 6.24

Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13

Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87

Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer (1976) 4.35

The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22

Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol (1995) 3.86

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A (1995) 3.85

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58

Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol (1988) 3.57

Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods (1995) 3.54

A massive binary black-hole system in OJ 287 and a test of general relativity. Nature (2008) 3.50

Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49

Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev (1996) 3.45

Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG (2006) 3.23

Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol (1970) 3.17

A primordial tRNA modification required for the evolution of life? EMBO J (2001) 3.01

The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96

K562--a human erythroleukemic cell line. Int J Cancer (1979) 2.84

Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv Cancer Res (1982) 2.68

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med (1987) 2.59

The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy (2007) 2.44

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst (2000) 2.41

Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood (1999) 2.38

Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol (1995) 2.37

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc Natl Acad Sci U S A (1995) 2.33

Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A (1991) 2.17

Classification and biological nature of established human hematopoietic cell lines. Int J Cancer (1975) 2.16

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A (1999) 2.14

Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology (1987) 2.11

Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08

High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int J Cancer (1971) 2.06

A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol (1989) 2.03

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res (1999) 1.90

Interventions during pregnancy to reduce excessive gestational weight gain: a systematic review assessing current clinical evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. BJOG (2010) 1.89

Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer (1977) 1.84

Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clin Microbiol Infect (2009) 1.76

Mast cells in innate immunity. Immunol Rev (2000) 1.76

Nasal continuous positive airway pressure: experiences with a new technical approach. Acta Paediatr (1993) 1.74

Transfer RNA modification: influence on translational frameshifting and metabolism. FEBS Lett (1999) 1.73

Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol (1994) 1.73

Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. Int J Cancer (1974) 1.73

Helicobacter pylori: host responses in peptic ulceration. Lancet (1993) 1.73

Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol (1992) 1.70

Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene (1994) 1.69

Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol (1991) 1.69

A genomic view of the sea urchin nervous system. Dev Biol (2006) 1.68

Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66

Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest (1995) 1.63

Diffuse axonal injury due to lateral head rotation in a rat model. J Neurosurg (2000) 1.63

Integration of telomere sequences with the draft human genome sequence. Nature (2001) 1.59

Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev (1974) 1.57

The mast cell. Crit Rev Immunol (1981) 1.56

An amplified fragment length polymorphism map of the silkworm. Genetics (2001) 1.54

Ultrastructural, biochemical, and functional characteristics of histamine-containing cells cloned from mouse bone marrow: tentative identification as mucosal mast cells. J Immunol (1983) 1.50

Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol (2004) 1.50

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47

Isolation and characterization of heparin from human lung. J Clin Invest (1979) 1.46

Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization. Cell Stress Chaperones (1998) 1.45

Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43

Natural killer cells kill tumour cells at a given stage of differentiation. Nature (1981) 1.43

Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42

Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. J Immunol (1995) 1.42

Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells. Leukemia (1989) 1.42

Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40

Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40

Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect Immun (1995) 1.39

A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. Hum Genet (1992) 1.39

C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol (1996) 1.37

Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds. Neuroreport (1999) 1.37

Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol (2002) 1.37

Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res (1983) 1.37

IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol (1993) 1.35

Formation and growth of multicellular spheroids of human origin. Int J Cancer (1983) 1.35

Phagocytosis of mast cell granules by cultured fibroblasts. J Immunol (1983) 1.34

In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr (1991) 1.34

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol (2000) 1.34

Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer (1981) 1.33

Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. Arthritis Rheum (1982) 1.29

Stem cell factor is a chemotactic factor for human mast cells. J Immunol (1994) 1.29

Entrapment of animal cells for production of monoclonal antibodies and other biomolecules. Nature (1983) 1.29

Stem cell factor induces mast cell adhesion to fibronectin. J Immunol (1994) 1.28

Circular chromosomal map of a temperate Bacillus phage. Virology (1967) 1.28

The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol (1997) 1.27

Expression and function of chemokine receptors in human multiple myeloma. Leukemia (2003) 1.26

Mast cell-T cell interactions. J Allergy Clin Immunol (1999) 1.26

Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage. Leukemia (1994) 1.25

Novel vaccine approaches. J Immunol (1996) 1.25

Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol (2000) 1.23

Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest (1981) 1.23

Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood (1992) 1.23

Evaluation of immediate adverse reactions to foods in adult patients. II. A detailed analysis of reaction patterns during oral food challenge. J Allergy Clin Immunol (1985) 1.23

Physiology of canine intraventricular conduction and endocardial excitation. Circ Res (1972) 1.22

Independent expression of the two HL-A antigen polypeptide chains. Eur J Immunol (1976) 1.22